Notizia: The Latest Pharma, Healthcare and Biotech Event Archives
Pfizer/ OPKO Health’s Somatrogon; FDA EU for SCONE device; Antengene ATG-010 for rrMM and rrDLBCL; S...
pharma-news-for-algernon-pieris-gaumard-hekka-labs
Algernon’s NP-120 (ifenprodil); Pieri...

Algernon receives positive FDA feedback on Phase IIb chronic cough trial The US Food and Drug Administratio...

medtech-news-for-abbott-abiomed-medtronic-alcon-calon-cardio-technology
Leman Micro Devices’ e-Checkup system...

Leman Micro Devices tested against the cuffed blood measurement devices reported positive results  On Janua...

pharma-news-for-noxxon-nuvalent-stryker-exact-sciences
Noxxon’s NOX-A12 clinical trial; Exac...

Noxxon continues enrolment in a glioblastoma therapy trial Noxxon Pharma continues subject enrolment in the...

medtech-news-for-siemens-paragon-28-pulnovo-endotronix-abbott
Siemens Healthineers’s COVID-19 Antigen Self-Test; Paragon’s R3ACT Stabilization System; Pulnovo ...

Siemens Healthineers received Emergency Use Authorization for CLINITEST® Rapid COVID-19 Antigen Self-Test by the FDA  On December 29, 2021, Siemens Healthineers was granted Emergency Use A...


pharma-news-for-accutar-bio-thera-nykode-heat-biologics-elusys
Accutar’s Phase I clinical trial for AC0176; Bio-Thera’s cancer drug, BAT6005; Nykode...

FDA approves IND application of Accutar for a prostate cancer treatment trial The US Food and Drug Administration (FDA) has granted Accutar Biotechnology’s Investigational New Drug (IND) applic...


medtech-news-for-cerner-scanwell-zynex-envista-sight-sciences
Cerner, Scanwell Health and Personal Genome Diagnostics Acquisition; Zynex’s Fluid Monitori...

Oracle Corporation sets to acquire Cerner Corporation  On December 20, 2021, Oracle Corporation and Cerner Corporation entered into an agreement as per which Oracle will acquire Cerner thr...


pharma-news-for-biogen-eisai-quidel-accutar-boehringer
Biogen-Eisai’s Aduhelm; Quidel acquires Ortho Clinical Diagnostics; Accutar Biotechnology’s...

Biogen-Eisai's potential Aduhelm sequel drug secured speedy review by FDA Biogen and Eisai’s Alzheimer’s disease treatment-in-waiting, lecanemab, has been secured a fast-track tag by the FDA, s...


medtech-news-for-zynex-foldax-bd-ge-edwards
Sky Medical’s Geko™ device; Fist Assist Devices obtains Breakthrough Device designation; E...

Sky receives FDA clearance to market the geko™ device for venous insufficiency and ischemia  On December 16, 2021, Sky Medical Technology Ltd, a medical device company, got approval...


pharma-news-for-edwards-lineage-novartis-koios-medical
Edwards’ Sapien 3 with Alterra Prestent; Koios Medical’s breast, thyroid cancer-spotting AI; Line...

Edwards secures FDA approval for Sapien 3 with Alterra Prestent for Transcatheter Pulmonic Valve Replacement Edwards Lifesciences declared to receive approval from the U.S. Food and Drug Admini...


Drug discovery to clinical development: Alzheimer’s disease treatment on the verge to change
Drug discovery to clinica...

It was assumed initially that Alzheimer’s Disease was a rare condition, but now it is considered t.....

Wet Age-related Macular Degeneration
Wet Age-related Macular D...

Wet Age-related Macular Degeneration (Wet-AMD) also referred to as Neovascular AMD (nAMD), is the mo.....

Cybersecurity of Medical Devices
Cybersecurity of Medical ...

The convergence of technologies and the increasing integration of medical devices to computer networ.....

Editor's Pick
22 Healthcare Trends & Innovations to Watch in 2022 and Beyond

With the advent of new-age healthcare industry trends that are evident as of now, there...

Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021

Although COVID-19 continued to dominate headlines in 2021, pharmaceutical companies did...

Analyzing the Key Trends Driving the Biosimilar Market Growth

The Biosimilars market is growing at a breakneck pace. The biosimilar market provides a...

CAR-T Cell Therapy aka Miraculous Technology: Mapping the Market, Approved Th...

Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative pot...

Myelodysplastic Syndromes (MDS): Key Pharma Players Unveiling Updated Finding...

There has been limited progress in the approval of novel agents in MDS. It has been a l...